Abiopharma

🔍 FITT LAWTON W (Director)

Company: Carlyle Group Inc. (CG)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 4,450 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 78,093.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These securities are a restricted stock unit award granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2027, subject to the reporting person's continued service on the Issuer's Board of Directors on such vesting date, and receipt of such shares shall be deferred to a future date pursuant to a deferral election made by the reporting person.